Increased inducible heat shock protein 72 expression associated with PBMC isolated from patients with haematological tumours

References

• Nylandsted J, Brand K, Jaattela M. Heat shock protein 70 is required for the survival of cancer cells. Ann N Y Acad Sci 2000;926:122–5.
   PubMed Web of Science ®Google Scholar
• Ciocca DR, Clark GM, Tandon AK, Fuqua SA, Welch WJ, McGuire WL. Heat shock protein hsp70 in patients with axillary lymph node-negative breast cancer: prognostic implications. J Natl Cancer Inst 1993;85:570–4.
   PubMed Web of Science ®Google Scholar
• Cornford PA, Dodson AR, Parsons KF, Desmond AD, Woolfenden A, Fordham M, Neoptolemos JP, Ke Y, Foster CS. Heat shock protein expression independently predicts clinical outcome in prostate cancer. Cancer Res 2000; 60:7099–105.
   PubMed Web of Science ®Google Scholar
• Blagosklonny MV. Re: role of the heat shock response and molecular chaperones in oncogenesis and cell death. J Natl Cancer Inst 2001;93:239–40.
   PubMedGoogle Scholar
• Hoang AT, Huang J, Rudra-Ganguly N, Zheng J, Powell WC, Rabindran SK, Wu C, Roy-Burman P. A novel association between the human heat shock transcription factor 1 (HSF1) and prostate adenocarcinoma. Am J Pathol 2000;156:857–64.
   PubMed Web of Science ®Google Scholar
• McMillan DR, Xiao X, Shao L, Graves K, Benjamin IJ. Targeted disruption of heat shock transcription factor 1 abolishes thermotolerance and protection against heat-inducible apoptosis. J Biol Chem 1998;273:7523–8.
   PubMed Web of Science ®Google Scholar
• Wang Y, Theriault JR, He H, Gong J, Calderwood SK. Expression of a dominant negative heat shock factor-1 construct inhibits aneuploidy in prostate carcinoma cells. J Biol Chem 2004;279:32651–9.
   PubMed Web of Science ®Google Scholar
• Wu C. Heat shock transcription factors: structure and regulation. Annu Rev Cell Dev Biol 1995;11:441–69.
   PubMed Web of Science ®Google Scholar
• Lazaris A, Chatzigianni EB, Panoussopoulos D, Tzimas GN, Davaris PS, Golematis B. Proliferating cell nuclear antigen and heat shock protein 70 immunolocalization in invasive ductal breast cancer not otherwise specified. Breast Cancer Res Treat 1997;43:43–51.
   PubMedGoogle Scholar
• Vargas-Roig LM, Gago FE, Tello O, Aznar JC, Ciocca DR. Heat shock protein expression and drug resistance in breast cancer patients treated with induction chemotherapy. Int J Cancer 1998;79:468–75.
   PubMed Web of Science ®Google Scholar
• Dempsey NC, Leoni F, Ireland HE, Hoyle C, Williams JH. Differential heat shock protein localization in chronic lymphocytic leukemia. J Leukoc Biol 2010;87:467–76.
   PubMed Web of Science ®Google Scholar
• Shanafelt TD, Geyer SM, Kay NE. Prognosis at diagnosis: integrating molecular biologic insights into clinical practice for patients with CLL. Blood 2004;103:1202–10.
   PubMed Web of Science ®Google Scholar
• Thomas X, Campos L, Mounier C, Cornillon J, Flandrin P, Le QH, Piselli S, Guyotat D. Expression of heat-shock proteins is associated with major adverse prognostic factors in acute myeloid leukemia. Leuk Res 2005;29: 1049–58.
   PubMed Web of Science ®Google Scholar
• Steiner K, Graf M, Hecht K, Reif S, Rossbacher L, Pfister K, Kolb HJ, Schmetzer HM, Multhoff G. High HSP70-membrane expression on leukemic cells from patients with acute myeloid leukemia is associated with a worse prognosis. Leukemia 2006;20:2076–9.
   PubMed Web of Science ®Google Scholar
• Bennett JM. The myelodysplastic/myeloproliferative disorders: the interface. Haematol Oncol Clin North Am 2003;17: 1095–100.
   PubMed Web of Science ®Google Scholar
• Saba HI. Myelodysplastic syndromes in the elderly: the role of growth factors in management. Leuk Res 1996;20:203–19.
   PubMed Web of Science ®Google Scholar
• Germing U, Gattermann N, Minning H, Heyll A, Aul C. Problems in the classification of CMML – dysplastic versus proliferative type. Leuk Res 1998;22:871–8.
   PubMed Web of Science ®Google Scholar
• Bowen DT. Chronic myelomonocytic leukemia: lost in classification? Haematol Oncol 2005;23:26–33.
   PubMed Web of Science ®Google Scholar
• Yeh CH, Tseng R, Zhang Z, Cortes J, O’Brien S, Giles F, Hannah A, Estrov Z, Keating M, Kantarjian H, Albitar M. Circulating heat shock protein 70 and progression in patients with chronic myeloid leukemia. Leuk Res 2009;33: 212–7.
   PubMed Web of Science ®Google Scholar
• Nylandsted J. Extracellular heat shock protein 70: a potential prognostic marker for chronic myeloid leukemia. Leuk Res 2009;33:205–6.
   PubMed Web of Science ®Google Scholar
• Madden LA, Sandstrom M, Lovell R, McNaughton L. Inducible heat shock protein 70 and its role in preconditioning and exercise. Amino Acids 2008;34:511–6.
   PubMed Web of Science ®Google Scholar
• Allegra A, Sant'antonio E, Penna G, Alonci A, D’Angelo A, Russo S, Cannavo A, Gerace D, Musolino C. Novel therapeutic strategies in multiple myeloma: role of the heat shock protein inhibitors. Eur J Haematol 2011;86:93–110.
   PubMed Web of Science ®Google Scholar
• Wells AD, Malkovsky M. Heat shock proteins, tumour immunogenicity and antigen presentation: an integrated view. Immunol Today 2000;23:130–5.
   Google Scholar
• Gehrmann M, Schmetzer H, Eissner G, Haferlach T, Hiddemann G, Multhoff G. Membrane-bound heat shock protein 70 (Hsp70) in acute myeloid leukemia: a tumour specific recognition structure for the cytolytic activity of autologous NK cells. Haematologica 2003;88:474–6.
   PubMed Web of Science ®Google Scholar
• Vince RV, Oliver K, Midgley AW, McNaughton LR, Madden LA. In vitro heat shock of human monocytes results in a proportional increase of inducible Hsp70 expression according to the basal content. Amino Acids 2010;38: 1423–8.
   PubMed Web of Science ®Google Scholar
• Suto R, Srivastava PK. A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science 1995;269:1585–8.
   PubMed Web of Science ®Google Scholar
• Vince RV, Midgley AW, Laden G, Madden LA. The effect of hyperbaric oxygen preconditioning on heat shock protein 72 expression following in vitro stress in human monocytes. Cell Stress Chaperones 2011;16:339–43.
   PubMed Web of Science ®Google Scholar
• Bachelet M, Mariethoz E, Banzet N, Souil E, Pinot F, Polla CZ, Durand P, Bouchaert I, Polla BS. Flow cytometry is a rapid and reliable method for evaluating heat shock protein 70 expression in human monocytes. Cell Stress Chaperones 1998;3:168–76.
   PubMed Web of Science ®Google Scholar
• Zhu J, Quyyumi AA, Wu H, Csako G, Rott D, Zalles-Ganley A, Ogunmakinwa J, Halcox J, Epstein SE. Increased serum levels of heat shock protein 70 are associated with low risk of coronary artery disease. Arterioscler Thromb Vasc Biol 2003;23:1055–9.
   PubMed Web of Science ®Google Scholar
• Hole PS, Darley RL, Tonks A. Do reactive oxygen species play a role in myeloid leukemias? Blood 2011;117:5816–26.
   PubMed Web of Science ®Google Scholar
• Currie RW, Karmazyn M, Kloc M, Mailer K. Heat-shock response is associated with enhanced postischemic ventricular recovery. Circ Res 1988;63:543–9.
   PubMed Web of Science ®Google Scholar
• Mocanu MM, Steare SE, Evans MC, Nugent JH, Yellon DM. Heat stress attenuates free radical release in the isolated perfused rat heart. Free Radic Biol Med 1993;15:459–63.
   PubMed Web of Science ®Google Scholar
• Gorman AM, Heavey B, Creagh E, Cotter TG, Samali A. Antioxidant-mediated inhibition of the heat shock response leads to apoptosis. FEBS Lett 1999;445:98–102.
   PubMed Web of Science ®Google Scholar
• Kerbauy DB, Deeg HJ. Apoptosis and antiapoptotic mechanisms in the progression of myelodysplastic syndrome. Exp Haematol 2007;35:1739–46.
   PubMed Web of Science ®Google Scholar
• Lin CW, Manshouri T, Jilani I, Neuberg D, Patel K, Kantarjian H, Andreeff M, Estrov Z, Beran M, Keating M, Estey E, Albitar M. Proliferation and apoptosis in acute and chronic leukemias and myelodysplastic syndrome. Leuk Res 2002;26:551–9.
   PubMed Web of Science ®Google Scholar
• Economopoulou C, Pappa V, Papageorgiou S, Kontsioti F, Economopoulou P, Charitidou E, Girkas K, Kapsimali V, Papasteriadi C, Tsirigotis P, Papageorgiou E, Dervenoulas J, Economopoulos T. Cell cycle and apoptosis regulatory gene expression in the bone marrow of patients with de novo myelodysplastic syndromes (MDS). Ann Haematol 2010;89: 349–58.
   PubMed Web of Science ®Google Scholar
• Biliran H, Jr., Wang Y, Banerjee S, Xu H, Heng H, Thakur A, Bollig A, Sarkar FH, Liao JD. Overexpression of cyclin D1 promotes tumour cell growth and confers resistance to cisplatin-mediated apoptosis in an elastase-myc transgene-expressing pancreatic tumour cell line. Clin Cancer Res 2005;11:6075–86.
   PubMed Web of Science ®Google Scholar
• Gabai VL, Meriin AB, Mosser DD, Caron AW, Rits S, Shifrin VI, Sherman MY. Hsp70 prevents activation of stress kinases. A novel pathway of cellular thermotolerance. J Biol Chem 1997;272:18033–7.
   PubMed Web of Science ®Google Scholar
• Christians ES, Yan LJ, Benjamin IJ. Heat shock factor 1 and heat shock proteins: critical partners in protection against acute cell injury. Crit Care Med 2002;30: S43–50.
   Web of Science ®Google Scholar
• Gabai VL, Yaglom JA, Volloch V, Meriin AB, Force T, Koutroumanis M, Massie B, Mosser DD, Sherman MY. Hsp72-mediated suppression of c-Jun N-terminal kinase is implicated in development of tolerance to caspase-independent cell death. Mol Cell Biol 2000;20:6826–36.
   PubMed Web of Science ®Google Scholar
• Mosser DD, Caron AW, Bourget L, Meriin AB, Sherman MY, Morimoto RI, Massie B. The chaperone function of hsp70 is required for protection against stress-induced apoptosis. Mol Cell Biol 2000;20:7146–59.
   PubMed Web of Science ®Google Scholar
• Schmitt E, Gehrmann M, Brunet M, Multhoff G, Garrido C. Intracellular and extracellular functions of heat shock proteins: repercussions in cancer therapy. J Leukoc Biol 2007;81:15–27.
   PubMed Web of Science ®Google Scholar
• Hantschel M, Pfister K, Jordan A, Scholz R, Andreesen R, Schmitz G, Schmetzer H, Hiddemann W, Multhoff G. Hsp70 plasma membrane expression on primary tumour biopsy material and bone marrow of leukemic patients. Cell Stress Chaperones 2000;5:438–42.
   PubMed Web of Science ®Google Scholar
• Loke J, Duffy TP. Normal arterial oxygen saturation with the ear oximeter in patients with leukemia and leukocytosis. Cancer 1984;53:1767–9.
   PubMed Web of Science ®Google Scholar